MC1317A1 - DERIVATIVES OF UREA - Google Patents
DERIVATIVES OF UREAInfo
- Publication number
- MC1317A1 MC1317A1 MC801437A MC1437A MC1317A1 MC 1317 A1 MC1317 A1 MC 1317A1 MC 801437 A MC801437 A MC 801437A MC 1437 A MC1437 A MC 1437A MC 1317 A1 MC1317 A1 MC 1317A1
- Authority
- MC
- Monaco
- Prior art keywords
- urea
- derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/30—Hetero atoms other than halogen
- C07D333/36—Nitrogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Plural Heterocyclic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CH241579 | 1979-03-14 | ||
CH17180 | 1980-01-10 |
Publications (1)
Publication Number | Publication Date |
---|---|
MC1317A1 true MC1317A1 (en) | 1981-03-10 |
Family
ID=25683737
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MC801437A MC1317A1 (en) | 1979-03-14 | 1980-03-14 | DERIVATIVES OF UREA |
Country Status (10)
Country | Link |
---|---|
EP (1) | EP0016371A1 (en) |
AU (1) | AU5628380A (en) |
DK (1) | DK108780A (en) |
ES (1) | ES489493A0 (en) |
FI (1) | FI800559A (en) |
GR (1) | GR66630B (en) |
IL (1) | IL59563A0 (en) |
MC (1) | MC1317A1 (en) |
NO (1) | NO800720L (en) |
PT (1) | PT70949B (en) |
Families Citing this family (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US7928239B2 (en) | 1999-01-13 | 2011-04-19 | Bayer Healthcare Llc | Inhibition of RAF kinase using quinolyl, isoquinolyl or pyridyl ureas |
ATE556713T1 (en) | 1999-01-13 | 2012-05-15 | Bayer Healthcare Llc | OMEGA-CARBOXYARYL SUBSTITUTED DIPHENYL UREAS AS P38 KINASE INHIBITORS |
US8124630B2 (en) | 1999-01-13 | 2012-02-28 | Bayer Healthcare Llc | ω-carboxyaryl substituted diphenyl ureas as raf kinase inhibitors |
WO2003068746A1 (en) | 2002-02-11 | 2003-08-21 | Bayer Pharmaceuticals Corporation | Aryl ureas as kinase inhibitors |
WO2003068229A1 (en) | 2002-02-11 | 2003-08-21 | Bayer Pharmaceuticals Corporation | Pyridine, quinoline, and isoquinoline n-oxides as kinase inhibitors |
AU2003209116A1 (en) | 2002-02-11 | 2003-09-04 | Bayer Pharmaceuticals Corporation | Aryl ureas with angiogenesis inhibiting activity |
US7557129B2 (en) | 2003-02-28 | 2009-07-07 | Bayer Healthcare Llc | Cyanopyridine derivatives useful in the treatment of cancer and other disorders |
PT1636585E (en) | 2003-05-20 | 2008-03-27 | Bayer Pharmaceuticals Corp | Diaryl ureas with kinase inhibiting activity |
JP4777887B2 (en) | 2003-07-23 | 2011-09-21 | バイエル、ファーマシューテイカルズ、コーポレイション | Fluoro-substituted omegacarboxyaryl diphenylureas for the treatment and prevention of diseases and conditions |
EP1751139B1 (en) | 2004-04-30 | 2011-07-27 | Bayer HealthCare LLC | Substituted pyrazolyl urea derivatives useful in the treatment of cancer |
Family Cites Families (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE2448869A1 (en) * | 1973-10-19 | 1975-09-04 | Mcneilab Inc | 4-OXO-2-IMIDAZOLIDINYLIDEN UREMENTS, THE METHOD OF MANUFACTURING THEREOF AND MEDICINAL PRODUCTS |
US3983135A (en) * | 1974-09-23 | 1976-09-28 | Mcneil Laboratories, Incorporated | 4-Oxo-2-imidazolidinylidene ureas |
US4025517A (en) * | 1975-06-23 | 1977-05-24 | Mcneil Laboratories, Incorporated | 4-Oxo-2-hexahydropyrimidinylidene ureas |
-
1980
- 1980-02-26 FI FI800559A patent/FI800559A/en not_active Application Discontinuation
- 1980-03-05 EP EP80101097A patent/EP0016371A1/en not_active Withdrawn
- 1980-03-07 AU AU56283/80A patent/AU5628380A/en not_active Abandoned
- 1980-03-10 IL IL59563A patent/IL59563A0/en unknown
- 1980-03-11 GR GR61403A patent/GR66630B/el unknown
- 1980-03-13 PT PT70949A patent/PT70949B/en unknown
- 1980-03-13 ES ES489493A patent/ES489493A0/en active Granted
- 1980-03-13 NO NO800720A patent/NO800720L/en unknown
- 1980-03-13 DK DK108780A patent/DK108780A/en unknown
- 1980-03-14 MC MC801437A patent/MC1317A1/en unknown
Also Published As
Publication number | Publication date |
---|---|
EP0016371A1 (en) | 1980-10-01 |
AU5628380A (en) | 1980-09-18 |
ES8103737A1 (en) | 1981-03-16 |
PT70949B (en) | 1981-06-24 |
GR66630B (en) | 1981-04-03 |
NO800720L (en) | 1980-09-15 |
PT70949A (en) | 1980-04-01 |
ES489493A0 (en) | 1981-03-16 |
DK108780A (en) | 1980-09-15 |
IL59563A0 (en) | 1980-06-30 |
FI800559A (en) | 1980-09-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
MC1355A1 (en) | IMIDAZODIAZEPINE DERIVATIVES | |
BR8002777A (en) | STRUCTURE OF BRACADEIRA | |
BR8002776A (en) | STRUCTURE OF BRACADEIRA | |
MC1220A1 (en) | NEW DERIVATIVES OF IMIDAZOLIDINE | |
MC1333A1 (en) | QUINAZOLINE DERIVATIVES | |
PL207986A1 (en) | METHOD OF THE PRODUCTION OF N'-PHENYL-N-METHYL UREA DERIVATIVES | |
MC1317A1 (en) | DERIVATIVES OF UREA | |
MC1184A1 (en) | OXADIAZOLOPYRIMIDINE DERIVATIVES | |
MC1143A1 (en) | DERIVATIVES OF THIOUREE | |
BR8002496A (en) | SET OF RAILS | |
FR2310344A1 (en) | PROCESS FOR THE PREPARATION OF CARBAMATE AND UREA DERIVATIVES | |
BE866208A (en) | DERIVATIVES OF HYDROGENATED ISOQUINOLEINE | |
MC1356A1 (en) | QUINAZOLINE DERIVATIVES | |
ES537338A0 (en) | DERIVATIVES OF PIRAZOL-PIRIDINA | |
MC1183A1 (en) | OXADIAZOLOPYRIMIDINE DERIVATIVES | |
BE859567A (en) | PIPERIDYLIDENIC DERIVATIVES OF BENZO-XANTHENS | |
MC1347A1 (en) | PYRIDAZOPYRIDAZINE DERIVATIVES | |
RO78871A (en) | METHOD FOR THE PREPARATION OF UREA DERIVATIVES METHOD FOR THE PREPARATION OF PYRIDIUREA AND PYRIDYLTHIOUREA DERIVATIVES | |
IT8048641A0 (en) | PROCEDURE FOR PURIFICATION OF THE ANTIBIOTIC SPECTINOMICIN | |
BE868590A (en) | ALPHA-ACETYLENIC AND ALPHA-VINYL DERIVATIVES OF AMINO ACIDS | |
BE854553A (en) | ISOTHIOUREA DERIVATIVES | |
BE879822A (en) | ERGOLINE DERIVATIVES | |
IT1194815B (en) | NEUROLETIC AGENTS OF HEXAIDRO-TRANS-PYRIDOINDOLS | |
BE865569A (en) | DERIVATIVES OF IMIDAZOLE. | |
MC1285A1 (en) | ISOQUINOLEIN DERIVATIVES |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
YP | Annual fee paid |